Family Medicine · Sparks, NV
NPI
1922085265
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
480 E Prater Way
Sparks, NV, 89431
Phone (775) 351-1300
Medicare paid, 2024
$93K
1,796 services
Medicare patients, 2024
235
Average age 75
Drug cost, 2024
$500K
6,059 prescriptions
Company payments, 2025
$33.4
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason S McKenzie was code 99214 (office e&m - established), 749 times for 233 patients. In total Jason S McKenzie billed 1,796 services in 27 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 749 | 233 | $70.88 | $53K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 379 | 188 | $10.53 | $3,992 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 188 | 20 | $0.62 | $117 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 187 | 187 | $118.64 | $22K |
| 90661 Vaccine Product | Office | 61 | 61 | $34.93 | $2,130 |
| G0008 Administration of influenza virus vaccine | Office | 59 | 59 | $31.72 | $1,871 |
| 99213 Office E&M - Established | Office | 29 | 22 | $58.50 | $1,697 |
| 96372 Injection Administration | Office | 22 | 13 | $9.52 | $209 |
| 17004 Destruction Skin Lesion | Office | 19 | 14 | $109.99 | $2,090 |
| 69210 Other Organ Systems | Office | 18 | 17 | $32.75 | $589 |
| 99204 Office E&M - New | Office | 15 | 15 | $73.13 | $1,097 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 14 | 14 | $140.19 | $1,963 |
| 20610 Joint Injection | Office | 13 | 11 | $30.44 | $396 |
By year: 2022 $123K for 8,078 services; 2023 $106K for 2,958 services; 2024 $93K for 1,796 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 15 | 12 | $3.18 | $47.74 |
Medicare prescription drug claims, 2024
In 2024, the drug Jason S McKenzie prescribed most often to Medicare patients was Atorvastatin Calcium, with 482 prescriptions and refills. In total Jason S McKenzie wrote 6,059 Medicare prescriptions that cost $500K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 482 | 1,156 | 116 | $5,964 |
| Amlodipine Besylate Generic | 380 | 963 | 90 | $2,337 |
| Levothyroxine Sodium Generic | 290 | 751 | 78 | $3,309 |
| Amlodipine-Valsartan Amlodipine Besylate/Valsartan | 225 | 452 | 54 | $13K |
| Valsartan Generic | 196 | 448 | 49 | $8,194 |
| Omeprazole Generic | 196 | 502 | 50 | $3,113 |
| Simvastatin Generic | 173 | 496 | 44 | $1,695 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 156 | 294 | 28 | $2,696 |
| Rosuvastatin Calcium Generic | 141 | 414 | 45 | $2,167 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 132 | 291 | 31 | $4,985 |
| Losartan Potassium Generic | 123 | 331 | 35 | $1,491 |
| Metformin Hcl Er Metformin Hcl | 116 | 271 | 33 | $649 |
| Hydrochlorothiazide Generic | 110 | 248 | 24 | $341 |
| Alendronate Sodium Generic | 109 | 200 | 19 | $1,141 |
| Pantoprazole Sodium Generic | 107 | 270 | 35 | $2,024 |
Brand drugs: 620 claims; generic drugs: 5,406 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason S McKenzie $33.4 ($33.4 in general payments such as food, travel and fees) from 2 companies. The largest payer was Merck Sharp & Dohme LLC with $17.8.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $17.8 |
| Xeris Pharmaceuticals, Inc. | 1 | $15.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.